Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |